Gsk (GLAXF) Inventory (2009 - 2026)

Gsk's Inventory history runs 18 years deep, the most recent figure standing at $8.3 billion for Q1 2026.

• In Q1 2026, Inventory rose 9.84% year-over-year to $8.3 billion; the TTM figure through Mar 2026 stood at $8.3 billion (up 9.84% YoY), while the FY2025 annual figure was $7.8 billion, up 7.79% from the prior year.
• Inventory was $8.3 billion for Q1 2026 at Gsk, up from $7.9 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.3 billion in Q1 2026 to a low of $1.3 billion in Q1 2022.
• Historically, Inventory has averaged $6.8 billion across 5 years, with a median of $7.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory tumbled 84.56% in 2022, then soared 391.97% in 2023.
• A 5-year view of Inventory shows it stood at $6.0 billion in 2022, then rose by 13.05% to $6.8 billion in 2023, then advanced by 6.63% to $7.3 billion in 2024, then rose by 8.3% to $7.9 billion in 2025, then climbed by 5.34% to $8.3 billion in 2026.
• The last three Inventory figures came in at $8.3 billion (Q1 2026), $7.9 billion (Q4 2025), and $8.3 billion (Q3 2025), per Business Quant data.